Cerebras Stock Hits All-Time Low: What's Happening?

Cerebras shares fell 11.46% to $96.67 Monday, a record low and roughly 75% below the May 14 peak of $386.34, after a short-seller report from Culper Research pressured the stock. Culper alleges the chips last 1.5–2.5 years versus the 3–5 years used in Cerebras’ accounting and raised concerns about the chip design, OpenAI contract, and a potential release of more than 50 million shares in early November; these remain allegations, not established facts. Technical indicators showed the shares oversold at an RSI of 24.9, with the 20-day moving average 26.8% above the price.

Analysis

The key issue is whether this is merely a float-and-sentiment washout or a repricing of Cerebras’ system economics. If the short seller’s useful-life claim is substantiated, shorter deployment life could mean more frequent customer replacement and weaker lifetime returns on deployed systems; the accounting consequence would be higher depreciation and potentially lower reported earnings, not an immediate cash outflow. Verify disclosures on actual system longevity, customer utilization, replacement rates, and the accounting assumptions before treating the allegation as fact. The OpenAI-contract challenge matters most if it exposes customer concentration or weakens evidence of repeatable demand; either would raise the risk premium on future growth.

Near term, any share unlock can add supply and volatility, but is not itself proof of insider selling or deteriorating fundamentals. Oversold conditions do not establish a floor: the break below prior lows and heavy selling make rallies vulnerable to renewed supply. Conversely, after the large drawdown, an outright short has meaningful squeeze risk, particularly if the technical breakdown reverses.

Over 1–3 months, watch the unlock’s actual selling, company responses with verifiable operating data, and any contract or customer updates. Over 6–18 months, the decisive question is whether Cerebras can demonstrate durable systems, repeat purchases, and attractive customer economics against alternative AI-compute approaches, including GPU and custom-chip offerings. The bearish thesis weakens on credible durability evidence and a sustained recovery above $104.18; it strengthens if disclosures validate shorter useful lives or demand concentration.

Key Decisions for Investors

• Avoid initiating an unhedged short solely on the report after the sharp decline; the short-covering and event-gap risk is asymmetric. Treat a sustained close above $104.18 as an initial invalidation of the immediate breakdown, not proof the fundamental concerns are resolved.
• For bearish exposure, consider a defined-risk put spread only if the stock fails to reclaim $104.18 and the borrow/option market is usable; size for a volatility spike and cap premium at risk. Do not rely on an assumed price target absent valuation and cash-flow data.
• Make the early-November share unlock an event watch: verify the number of shares actually eligible, holders’ sale restrictions, and reported selling. Eligible shares are potential supply, not guaranteed sales; a lack of selling would reduce the near-term technical-overhang case.
• Before adding exposure, seek evidence on system useful life versus accounting estimates, customer concentration and repeat orders, and the economics of replacing deployed systems. Falsification of the short thesis would be independently verifiable durability and recurring demand; confirmation would warrant reassessing earnings quality and the growth multiple.